(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | (Q2)Feb 28, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -42.59%-5.34M | -1.8M | -228.08%-720.48K | -84.04%-1.65M | -1.17M | 18.10%-3.75M | -1,092.09%-4.57M | -1,639.68%-3.08M | 425.25%562.51K | -3,507.18%-899.23K |
Net income from continuing operations | -79.71%-8M | ---1.59M | -296.43%-2.43M | -67.66%-1.8M | ---2.19M | 53.83%-4.45M | -998.06%-9.64M | -819.25%-7.12M | 686.21%1.24M | -2,027.23%-1.07M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 1,459.40%7.74K | -102.54%-569 | --0 | ---71.83K | --37.67K |
Depreciation and amortization | 85.59%252.17K | --69.32K | --67.1K | --59.3K | --56.45K | -12.17%135.88K | 103,030.00%154.7K | 75,675.33%113.66K | ---- | ---- |
Asset impairment expenditure | --0 | --0 | --0 | ---- | ---- | --0 | 5,595.51%2.13M | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Remuneration paid in stock | 57.24%1.7M | --25.24K | 3,412.15%937.99K | 73.03%280.89K | --457.16K | 68.64%1.08M | 96.14%641.55K | 10.06%359.99K | --26.71K | --162.34K |
Other non cashItems | 2,207.03%22.19K | --2.24K | 100.70%4.46K | 141.67%6.65K | --8.83K | -100.03%-1.05K | --3.18M | --1.96M | ---636.66K | ---15.97K |
Change In working capital | 231.78%683.49K | ---306.7K | 2,223.62%698.1K | -1,128.63%-206.1K | --498.2K | 49.85%-518.66K | -743.62%-1.03M | -488.86%-522.32K | -186.69%-32.87K | -103.68%-16.78K |
-Change in receivables | -96.56%-639.31K | ---557.27K | 727.44%501.6K | -5,892.30%-556.41K | ---27.23K | 32.57%-325.25K | ---482.37K | -8,528.64%-353.75K | -1,804.79%-79.94K | --9.61K |
-Change in inventory | -35.56%186.05K | ---148.28K | 48.23%299.23K | 134.99%162.58K | ---127.48K | 129.82%288.71K | ---968.04K | ---675.53K | --201.87K | ---464.58K |
-Change in prepaid assets | 155.88%463.91K | --143.03K | -45.35%106.37K | -147.00%-32.5K | --247.01K | -124.61%-830.15K | -790.57%-369.6K | -326.40%-172.7K | 19,562.80%194.63K | --69.15K |
-Change in payables and accrued expense | 45.98%473.81K | --291.11K | -4,481.71%-277.51K | 479.77%107.09K | --353.13K | -11.50%324.58K | 81.39%366.76K | 56.96%267.82K | -114.05%-6.06K | 324.27%18.47K |
-Change in other working capital | 749.08%199.03K | ---35.28K | 119.92%68.4K | --113.14K | --52.78K | -94.41%23.44K | --419.05K | --411.84K | ---343.37K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -42.59%-5.34M | ---1.8M | -228.08%-720.48K | -84.04%-1.65M | ---1.17M | 18.10%-3.75M | -1,092.09%-4.57M | -1,639.68%-3.08M | 425.25%562.51K | -3,507.18%-899.23K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -294.99%-36.44K | 11.59K | -117.96%-62.84K | 119.95%6.4K | 8.42K | 107.78%18.69K | -6.20%-240.07K | -85.04%-290.3K | 350K | -139.71%-32.1K |
Net PPE purchase and sale | -391.62%-188.54K | ---26.44K | -172.67%-100.87K | 1.49%-31.62K | ---29.61K | 62.82%-38.35K | -3,722.83%-103.14K | -5,211.42%-143.3K | --138.81K | ---32.1K |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | 27.12%-147K | ---- | ---- | --0 |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net other investing changes | 166.67%152.1K | --38.03K | -80.87%38.03K | --38.03K | --38.03K | 466.57%57.04K | --10.07K | --0 | --198.79K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -294.99%-36.44K | --11.59K | -117.96%-62.84K | 119.95%6.4K | --8.42K | 107.78%18.69K | -6.20%-240.07K | -85.04%-290.3K | --350K | -139.71%-32.1K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,465.46%5.19M | -78.52K | 97.55%-77.3K | -95.39%-54.28K | 5.4M | -104.43%-380.23K | 147.22%8.58M | 995.28%8.62M | -217.39%-3.15M | -27.78K |
Net issuance payments of debt | -58.65%-309.96K | ---78.52K | -752.70%-77.3K | -177.43%-77.07K | ---77.07K | -9.71%-195.38K | ---178.08K | ---143.95K | --11.84K | ---27.78K |
Net common stock issuance | --4.92M | --0 | --0 | --4.04K | --4.92M | --0 | 26.07%3.35M | 11,361.07%3.35M | -217.83%-3.16M | --0 |
Proceeds from stock option exercised by employees | 1,232.02%582.41K | --0 | --0 | --18.75K | --563.66K | --43.72K | --0 | --0 | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -104.22%-228.58K | 563.03%5.41M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,465.46%5.19M | ---78.52K | 97.55%-77.3K | -95.39%-54.28K | --5.4M | -104.43%-380.23K | 147.22%8.58M | 995.28%8.62M | -217.39%-3.15M | ---27.78K |
Net cash flow | ||||||||||
Beginning cash position | -60.46%2.69M | --4.37M | 37.96%5.22M | 46.00%6.93M | --2.69M | 124.72%6.79M | 1,784.55%3.02M | -9.22%2.33M | 6,475.73%3.79M | 285,732.89%4.74M |
Current changes in cash | 95.47%-185.92K | ---1.86M | 61.58%-860.62K | -77.54%-1.7M | --4.24M | -208.94%-4.11M | 31.71%3.77M | 1,058.64%5.25M | -189.15%-2.24M | -1,815.43%-959.11K |
Effect of exchange rate changes | ---3.18K | ---6.28K | --5.54K | ---2.05K | ---383 | --0 | ---- | ---- | ---- | ---- |
End cash Position | -7.04%2.5M | --2.5M | 87.20%4.37M | 37.96%5.22M | --6.93M | -60.46%2.69M | 124.72%6.79M | 124.72%6.79M | -9.22%2.33M | 6,475.73%3.79M |
Free cash from | -46.12%-5.53M | ---1.82M | -227.02%-821.35K | -81.09%-1.69M | ---1.2M | 20.02%-3.78M | -1,124.61%-4.73M | -1,693.28%-3.22M | 473.90%646.65K | -3,635.94%-931.33K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.